YKYujin Ko

Yujin Ko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yujin Ko has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Efficacy of a Prescription-Based Mobile Digital Therapeutic as an Adjunct to Pharmacotherapy for the Acute Phase of Panic Disorder: Multicenter Randomized Controlled Trial

    by Yujin Ko, Junhyung Kim, Sunyoung Park, Hyunkyu Kim, June-Ho Seo, Il Ho Park, Jeemin Lee, Jae-Jin Kim

    Background: Although pharmacotherapy is the primary treatment for patients with acute-phase panic disorder, its incomplete efficacy causes them to experience frequent panic attacks and severe anticipatory anxiety for a considerable period. A prescription-based mobile digital therapeutic (DTx) that integrates self-guided cognitive behavioral therapy (CBT), real-time symptom management, and lifestyle tracking can be used as an adjunct to pharmacotherapy for these patients, helping them achieve rapid symptom recovery. Objective: This study aimed to evaluate the efficacy of this adjunctive DTx in alleviating symptoms in patients with acute-phase panic disorder. Methods: In total, 66 acute-phase patients experiencing frequent panic attacks were recruited from 6 institutions and randomly divided into a group receiving pharmacotherapy combined with DTx or pharmacotherapy alone, participating in an 8-week multicenter single-blind trial. The DTx app included 3 major services: training service consisting of structured CBT modules, companion service of just-in-time modules for coping with panic attacks, and care service providing daily self-management tracking tools. The self-report scales used as efficacy indicators were administered via paper questionnaires during a total of 4 visits at baseline, week 2, week 4, and week 8. The primary end point, the change in the Panic Disorder Severity Scale-Self Report (PDSS-SR) score, and the secondary end points, such as changes in overall anxiety, depression, panic-related catastrophic cognitions, and fear of bodily sensations, were compared between the 2 groups. Adherence to the DTx was objectively assessed using device use metrics. Results: As 5 enrolled patients were excluded due to insufficient safety analysis or efficacy evaluation, the final analysis included 32 in the DTx group and 29 in the control group. The DTx group showed a significantly greater reduction in PDSS-SR scores at week 8 compared to the control group (mean 40.29%, SD 26.68% vs mean 17.61%, SD 30.37%; P =.007). This therapeutic benefit appeared rapidly by week 2 (mean 26.66%, SD 22.03% vs mean 11.05%, SD 21.73%; P =.02). The responder (≥40% PDSS-SR reduction) rate was also significantly higher in the DTx group (17/32, 53.12% vs 5/29, 17.24%; P =.007). While changes in depression and somatic fears were transient or similar between groups, the DTx group showed significantly greater sustained improvements in overall anxiety and catastrophic cognitions. The overall mean adherence rate was 78.12%, with no significant difference between responders and nonresponders. Conclusions: The adjunctive use of our prescription-based DTx resulted in early and sustained symptom reductions across panic severity, overall anxiety, and catastrophic cognitions, suggesting that this multifunctional and self-guided DTx including just-in-time management and lifestyle tracking can serve as a practical complement to routine psychiatric care for acute-phase patients experiencing frequent panic attacks. This app is expected to present a new framework for the treatment of acute-phase panic disorder by enabling the incorporation of various symptomatic aspects in patients’ daily life into clinicians’ evaluations and guidance in the clinic.

  • Open Access

    Development and Pilot Evaluation of a Drug Abuse Prevention Program for Elementary School Children in Korea

    by Jeewon Lee, Jaewon Yang, Areum Lee, Yujin Ko, Jae Kwang Shim, Soyoung Irene Lee

    Objective The purpose of the present study was to develop and pilot test a culturally tailored, developmentally appropriate, drug abuse prevention program for Korean elementary school children.Methods By grounding the program in the framework of Social and Emotional Learning (SEL), the program aimed to prevent drug abuse by enhancing children’s social and emotional competencies. Separate curricula were developed for lower and upper elementary to align with children’s cognitive and socio-emotional developmental stages. Expert feedback was solicited from child psychiatrists and elementary school teachers. The program was implemented in an elementary school with 194 participants. Program feasibility and acceptability were assessed through facilitator evaluations and student satisfaction surveys. For upper elementary students (n=99), pre–post measures of self-esteem and attitudes toward drug abuse were also analyzed.Results Experts and facilitators reported that the program was easy to implement, developmentally appropriate, and well understood by students. Satisfaction surveys indicated high levels of engagement and perceived learning. The mean self-esteem score increased from 27.3±4.2 to 28.2±3.9 (Cohen’s d=0.21). The attitude toward drug abuse score also improved from 15.2±2.3 to 15.6±3.1 (Cohen’s d=0.14). Although both changes did not reach statistical significance, the qualitative and quantitative data support the program’s feasibility and positive trend.Conclusion This pilot study suggests that an SEL-based, culturally adapted prevention program is feasible and well accepted in Korean elementary schools. While larger-scale studies are required, early implementation of interactive, developmentally sensitive programs holds promise for strengthening protective factors against drug abuse in children.

  • Open Access

    Psychosocial and Behavioral Correlates of Self-Rated Health in Psychiatric Outpatients and Community Adults

    by Yujin Ko, Shin-Gyeom Kim, Soyoung Irene Lee, Jeewon Lee, Han-Yong Jung, HyunChul Youn

    Objective This study aimed to identify psychosocial and behavioral factors influencing self-rated health-related quality of life (HRQoL) in psychiatric and community settings.Methods Cross-sectional data were collected from 128 psychiatric outpatients and 500 general population participants. HRQoL was measured using the EuroQol Visual Analogue Scale (EQ-VAS). Psychological and behavioral variables included the Patient Health Questionnaire-9, Generalized Anxiety Disorder-7, Connor–Davidson Resilience Scale, Pittsburgh Sleep Quality Index, Morningness–Eveningness Questionnaire, Charlson Comorbidity Index, and Multidimensional Scale of Perceived Social Support. Separate stepwise multiple linear regression analyses were conducted for each group to identify factors associated with EQ-VAS scores.Results In the psychiatric sample, sleep quality and family cohabitation were positively associated with HRQoL. In the general population, HRQoL was significantly related to depressive symptoms, resilience, comorbidity burden, body mass index, sleep quality, and morningness preference. Each group showed a distinct pattern of associations, reflecting their respective psychosocial contexts.Conclusion Results indicate that HRQoL is affected by a complex interplay of emotional, behavioral, and environmental factors, which vary by population. Interventions to improve subjective health may benefit from addressing sleep and social support in psychiatric clinical settings, and broader lifestyle and emotional health in community contexts.

  • Open Access

    Clinical Features of Adults With Attention Deficit/Hyperactivity Disorder, Focusing on Their Adherence to Medication

    by Jae Kwang Shim, Soyoung Irene Lee, Shim-Gyeom Kim, Yujin Ko, HyunChul Youn, Jeewon Lee

    Objective The purpose of the present study was to examine the clinical features and medication adherence of the patients diagnosed with attention deficit/hyperactivity disorder (ADHD) in their adulthood.Methods The present study involved a retrospective chart review of the adults who were diagnosed with ADHD during the period of March 2016 to February 2021 at a university-based, tertiary hospital in South Korea. Two-year follow-up medical records of the participants after they were diagnosed with ADHD were reviewed.Results The eligible sample consisted of 174 adults with ADHD (mean age, 25.14±7.84; male, 73.6%). Only 56.3% the subjects had sought treatment because of their ADHD symptoms and others had other chief complaints such as interpersonal relationship problems and depressed mood. One or more psychiatric comorbidities were found in 76.4% of the subjects. Only 42.6% of methylphenidate group showed higher adherence than 80%, and 40.0% of atomoxetine group showed higher adherence than 80%. Only 13.8% of methylphenidate group and 18.2% of atomoxetine group showed longer persistence than 365 days. None of the subjects had any substance-related events regarding ADHD medication.Conclusion ADHD not only persists into adulthood but is associated with a wide range of psychiatric symptoms and comorbidities. Clinicians should constantly consider the possibility of ADHD when evaluating adult patients. Most importantly, greater emphasis should be placed on improving adherence to pharmacological treatment rather than on the relatively minimal risk of medication abuse or misuse. Enhancing treatment adherence in adults with ADHD has the potential to significantly improve functioning across multiple domains.

  • Open Access

    Assessing the Usability of a Prescription-Based Mobile App for Patients With Panic Disorder and Its Management Console for Clinicians: Controlled User Study

    by Yujin Ko, Jeemin Lee, Kyunghee Ham, Yesol Cho, Yu-Bin Shin, Choongki Min, Kyungnam Kim, Wonseuk Jang, Hayeon Jung, Jae-Jin Kim

    Background: Panic disorder is characterized by sudden panic attacks and persistent anticipatory anxiety. While pharmacotherapy remains effective, patients with panic disorder often experience residual symptoms and functional impairments. Lifestyle factors influence symptom severity but are often unaddressed in routine psychiatric care. Most current digital therapeutics for panic disorder have a limited scope, lack integration with clinicians, and fail to consider behavioral patterns. To address these limitations, our research team developed a prescription-based app that supports structured cognitive behavioral therapy practice, real-life symptom management, and lifestyle modifications for patients with panic disorder, and a management console—a web-based platform that allows clinicians to monitor the patients’ engagement and progress as well as determine therapeutic options if necessary. Objective: This study aimed to test the usability of the app and management console by evaluating their interface, functionality, and user experience. The primary goal was to identify the strengths and areas for further improvement of these software devices and to develop a list of modifications to improve the user experience and clinical applicability in updates to refine the devices for a future clinical trial. Methods: Usability data were collected by investigators at a medical device usability research center without the involvement of the development research team, and the participants were 15 patients with panic disorder and 15 psychiatrists. Each group completed experimental use of the app or management console and scored the convenience and safety of its modules, questionnaire evaluations for the acceptability, and presentation of verbal subjective feedback on areas for improvement. Based on the participants’ suggestions, a list of items that need to be modified to improve functionality and ease of use for each device was created. Results: Patients completed 155 assigned tasks for the app with more than 98% success, and psychiatrists completed 34 tasks for the management console with more than 86% success. The convenience and safety scores for the app and management console exceeded the neutral threshold (mean >4.5). For all statements about the acceptability, both patients and psychiatrists responded at the level of agreeing with a score exceeding 3 (mean: 3.6~4.3 and 4~4.7, respectively). There were 38 suggestions for app improvements and 66 suggestions for management console improvements, most of which were incorporated in the modification list. Conclusions: Patients reported that the app might be easy to use and help manage anxiety, and psychiatrists found the management console practical and well-suited for outpatients. By combining patient-facing therapeutic tools with clinician-driven prescription and monitoring, the devices offer a solution aligned with clinically integrated, real-world psychiatric care. Modified devices based on the improvement suggestions presented in this study will be evaluated in future clinical trials for their impact on engagement and treatment outcomes.


  • Dexamethasone therapy prevents delayed neuropsychiatric sequelae after carbon monoxide poisoning: a prospective registry-based study

    by Sechan Kim, Sungwoo Choi, Yujin Ko, Choung Ah Lee, Gi Woon Kim, Ji Eun Moon, Sangun Nah, Sangsoo Han

    Delayed neuropsychiatric sequelae are major complications of carbon monoxide poisoning; carbon monoxide triggers brain oxidation and inflammation. Corticosteroids such as dexamethasone modulate neu...


  • Open Access

    The Effect of Suicide Prevention Education on Attitudes Toward Suicide in Police Officers

    by Yujin Ko, HyunChul Youn, Soyoung Irene Lee, Jeewon Lee, Areum Lee, Shin-Gyeom Kim

    Objective This study investigated the effect of suicide prevention education on attitudes toward suicide among police officers.Methods We used an anonymous questionnaire for 518 officers and surveyed the demographic profiles and examined attitudes toward suicide utilizing the Attitudes Towards Suicide Scale (ATTS) (1=totally agree, 5=totally disagree). Our study divided participants into two groups, based on whether or not they had received suicide prevention education, and examined the differences in attitudes toward suicide between the groups.Results Of the total population, 247 (47.7%) officers had received suicide prevention education. The education group thought suicide as a predictable matter, disagreeing significantly more with the ATTS factor ‘suicide is unpredictable’ (3.36 vs. 3.35; p=0.001) compared with the no education group. Also, the education group more perceived suicide as a cry for help and at the same time disagreed more with the notion ‘suicidal thoughts will never disappear’ (2.08 vs. 2.26; p=0.025, 3.2 vs. 3.05; p=0.035, respectively).Conclusion Officers with experience in suicide prevention education showed more positive attitude toward suicide and suicide prevention. These findings suggest a need to organize more opportunities of suicide prevention educations, such as making the training mandatory for police officers.